"In vivo" anti-hCG antibodies and Yoshida's tumor development.
The anti-hCG antibodies, obtained from the rats immunized with hCG and tetanus toxoid causes slight delay in the formation of ascites liquid and increase of the survival rate in various groups of rats transplanted with Yoshida's tumor.